APO Research
Talk to an analyst

APO RESEARCH · REPORT

Furazolidone

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Furazolidone Market Analysis and Forecast 2026-2032

19 December 2025199 pages

Choose your research edition.

Industry ResearchFurazolidone Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Furazolidone Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Furazolidone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Furazolidone Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Furazolidone Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Furazolidone market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Furazolidone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Furazolidone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Furazolidone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Furazolidone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Furazolidone include Becton, Dickinson and Company (BD), Daiichi Sankyo, Ferring, Geo-Med, GrÜNenthal Gmbh, Keyfarm, KPL Pharma, Marvi and Standpharm, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Furazolidone, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Furazolidone, also provides the sales of main regions and countries. Of the upcoming market potential for Furazolidone, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Furazolidone sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Furazolidone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Furazolidone sales, projected growth trends, production technology, application and end-user industry.

Furazolidone Segment by Company

Becton, Dickinson and Company (BD)

Daiichi Sankyo

Ferring

Geo-Med

GrÜNenthal Gmbh

Keyfarm

KPL Pharma

Marvi

Standpharm

Teva

Furazolidone Segment by Type

Pharma Grade

Industrial Grade

Others

Furazolidone Segment by Application

Pharmacy

Industry

Furazolidone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Furazolidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Furazolidone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Furazolidone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Furazolidone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Furazolidone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Furazolidone sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Furazolidone Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Pharma Grade Major Manufacturers Table 3. Industrial Grade Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Furazolidone Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Pharmacy Major Manufacturers Table 7. Industry Major Manufacturers Table 8. Furazolidone Industry Trends Table 9. Furazolidone Industry Drivers Table 10. Furazolidone Industry Opportunities and Challenges Table 11. Furazolidone Industry Restraints Table 12. Global Furazolidone Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Furazolidone Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Furazolidone Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Furazolidone Revenue Market Share by Region (2021-2026) Table 16. Global Furazolidone Revenue Market Share by Region (2027-2032) Table 17. Global Furazolidone Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Furazolidone Sales by Region (2021-2026) & (K Units) Table 19. Global Furazolidone Sales by Region (2027-2032) & (K Units) Table 20. Global Furazolidone Sales Market Share by Region (2021-2026) Table 21. Global Furazolidone Sales Market Share by Region (2027-2032) Table 22. Global Furazolidone Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Furazolidone Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Furazolidone Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Furazolidone Sales Market Share by Manufacturers (2021-2026) Table 26. Global Furazolidone Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Furazolidone Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Furazolidone Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Furazolidone Manufacturers, Product Type & Application Table 30. Global Furazolidone Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Furazolidone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Furazolidone Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Furazolidone Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Furazolidone Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Furazolidone Revenue Market Share by Type (2021-2026) Table 37. Global Furazolidone Revenue Market Share by Type (2027-2032) Table 38. Global Furazolidone Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Furazolidone Sales by Type (2021-2026) & (K Units) Table 40. Global Furazolidone Sales by Type (2027-2032) & (K Units) Table 41. Global Furazolidone Sales Market Share by Type (2021-2026) Table 42. Global Furazolidone Sales Market Share by Type (2027-2032) Table 43. Global Furazolidone Price by Type (2021-2026) & (US$/Unit) Table 44. Global Furazolidone Price by Type (2027-2032) & (US$/Unit) Table 45. Global Furazolidone Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Furazolidone Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Furazolidone Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Furazolidone Revenue Market Share by Application (2021-2026) Table 49. Global Furazolidone Revenue Market Share by Application (2027-2032) Table 50. Global Furazolidone Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Furazolidone Sales by Application (2021-2026) & (K Units) Table 52. Global Furazolidone Sales by Application (2027-2032) & (K Units) Table 53. Global Furazolidone Sales Market Share by Application (2021-2026) Table 54. Global Furazolidone Sales Market Share by Application (2027-2032) Table 55. Global Furazolidone Price by Application (2021-2026) & (US$/Unit) Table 56. Global Furazolidone Price by Application (2027-2032) & (US$/Unit) Table 57. Becton, Dickinson and Company (BD) Company Information Table 58. Becton, Dickinson and Company (BD) Business Overview Table 59. Becton, Dickinson and Company (BD) Furazolidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Becton, Dickinson and Company (BD) Furazolidone Product Portfolio Table 61. Becton, Dickinson and Company (BD) Recent Development Table 62. Daiichi Sankyo Company Information Table 63. Daiichi Sankyo Business Overview Table 64. Daiichi Sankyo Furazolidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Daiichi Sankyo Furazolidone Product Portfolio Table 66. Daiichi Sankyo Recent Development Table 67. Ferring Company Information Table 68. Ferring Business Overview Table 69. Ferring Furazolidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Ferring Furazolidone Product Portfolio Table 71. Ferring Recent Development Table 72. Geo-Med Company Information Table 73. Geo-Med Business Overview Table 74. Geo-Med Furazolidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Geo-Med Furazolidone Product Portfolio Table 76. Geo-Med Recent Development Table 77. GrÜNenthal Gmbh Company Information Table 78. GrÜNenthal Gmbh Business Overview Table 79. GrÜNenthal Gmbh Furazolidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. GrÜNenthal Gmbh Furazolidone Product Portfolio Table 81. GrÜNenthal Gmbh Recent Development Table 82. Keyfarm Company Information Table 83. Keyfarm Business Overview Table 84. Keyfarm Furazolidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Keyfarm Furazolidone Product Portfolio Table 86. Keyfarm Recent Development Table 87. KPL Pharma Company Information Table 88. KPL Pharma Business Overview Table 89. KPL Pharma Furazolidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. KPL Pharma Furazolidone Product Portfolio Table 91. KPL Pharma Recent Development Table 92. Marvi Company Information Table 93. Marvi Business Overview Table 94. Marvi Furazolidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Marvi Furazolidone Product Portfolio Table 96. Marvi Recent Development Table 97. Standpharm Company Information Table 98. Standpharm Business Overview Table 99. Standpharm Furazolidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Standpharm Furazolidone Product Portfolio Table 101. Standpharm Recent Development Table 102. Teva Company Information Table 103. Teva Business Overview Table 104. Teva Furazolidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Teva Furazolidone Product Portfolio Table 106. Teva Recent Development Table 107. North America Furazolidone Revenue by Type (2021-2026) & (US$ Million) Table 108. North America Furazolidone Revenue by Type (2027-2032) & (US$ Million) Table 109. North America Furazolidone Sales by Type (2021-2026) & (K Units) Table 110. North America Furazolidone Sales by Type (2027-2032) & (K Units) Table 111. North America Furazolidone Sales Price by Type (2021-2026) & (US$/Unit) Table 112. North America Furazolidone Sales Price by Type (2027-2032) & (US$/Unit) Table 113. North America Furazolidone Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Furazolidone Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Furazolidone Sales by Application (2021-2026) & (K Units) Table 116. North America Furazolidone Sales by Application (2027-2032) & (K Units) Table 117. North America Furazolidone Sales Price by Application (2021-2026) & (US$/Unit) Table 118. North America Furazolidone Sales Price by Application (2027-2032) & (US$/Unit) Table 119. North America Furazolidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Furazolidone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. North America Furazolidone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. North America Furazolidone Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 123. North America Furazolidone Sales by Country (2021-2026) & (K Units) Table 124. North America Furazolidone Sales by Country (2027-2032) & (K Units) Table 125. North America Furazolidone Sales Price by Country (2021-2026) & (US$/Unit) Table 126. North America Furazolidone Sales Price by Country (2027-2032) & (US$/Unit) Table 127. United States Furazolidone Revenue (2021-2032) & (US$ Million) Table 128. Canada Furazolidone Revenue (2021-2032) & (US$ Million) Table 129. Europe Furazolidone Revenue by Type (2021-2026) & (US$ Million) Table 130. Europe Furazolidone Revenue by Type (2027-2032) & (US$ Million) Table 131. Europe Furazolidone Sales by Type (2021-2026) & (K Units) Table 132. Europe Furazolidone Sales by Type (2027-2032) & (K Units) Table 133. Europe Furazolidone Sales Price by Type (2021-2026) & (US$/Unit) Table 134. Europe Furazolidone Sales Price by Type (2027-2032) & (US$/Unit) Table 135. Europe Furazolidone Revenue by Application (2021-2026) & (US$ Million) Table 136. Europe Furazolidone Revenue by Application (2027-2032) & (US$ Million) Table 137. Europe Furazolidone Sales by Application (2021-2026) & (K Units) Table 138. Europe Furazolidone Sales by Application (2027-2032) & (K Units) Table 139. Europe Furazolidone Sales Price by Application (2021-2026) & (US$/Unit) Table 140. Europe Furazolidone Sales Price by Application (2027-2032) & (US$/Unit) Table 141. Europe Furazolidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Europe Furazolidone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 143. Europe Furazolidone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 144. Europe Furazolidone Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 145. Europe Furazolidone Sales by Country (2021-2026) & (K Units) Table 146. Europe Furazolidone Sales by Country (2027-2032) & (K Units) Table 147. Europe Furazolidone Sales Price by Country (2021-2026) & (US$/Unit) Table 148. Europe Furazolidone Sales Price by Country (2027-2032) & (US$/Unit) Table 149. Germany Furazolidone Revenue (2021-2032) & (US$ Million) Table 150. France Furazolidone Revenue (2021-2032) & (US$ Million) Table 151. U.K. Furazolidone Revenue (2021-2032) & (US$ Million) Table 152. Italy Furazolidone Revenue (2021-2032) & (US$ Million) Table 153. Netherlands Furazolidone Revenue (2021-2032) & (US$ Million) Table 154. China Furazolidone Revenue by Type (2021-2026) & (US$ Million) Table 155. China Furazolidone Revenue by Type (2027-2032) & (US$ Million) Table 156. China Furazolidone Sales by Type (2021-2026) & (K Units) Table 157. China Furazolidone Sales by Type (2027-2032) & (K Units) Table 158. China Furazolidone Sales Price by Type (2021-2026) & (US$/Unit) Table 159. China Furazolidone Sales Price by Type (2027-2032) & (US$/Unit) Table 160. China Furazolidone Revenue by Application (2021-2026) & (US$ Million) Table 161. China Furazolidone Revenue by Application (2027-2032) & (US$ Million) Table 162. China Furazolidone Sales by Application (2021-2026) & (K Units) Table 163. China Furazolidone Sales by Application (2027-2032) & (K Units) Table 164. China Furazolidone Sales Price by Application (2021-2026) & (US$/Unit) Table 165. China Furazolidone Sales Price by Application (2027-2032) & (US$/Unit) Table 166. Asia Furazolidone Revenue by Type (2021-2026) & (US$ Million) Table 167. Asia Furazolidone Revenue by Type (2027-2032) & (US$ Million) Table 168. Asia Furazolidone Sales by Type (2021-2026) & (K Units) Table 169. Asia Furazolidone Sales by Type (2027-2032) & (K Units) Table 170. Asia Furazolidone Sales Price by Type (2021-2026) & (US$/Unit) Table 171. Asia Furazolidone Sales Price by Type (2027-2032) & (US$/Unit) Table 172. Asia Furazolidone Revenue by Application (2021-2026) & (US$ Million) Table 173. Asia Furazolidone Revenue by Application (2027-2032) & (US$ Million) Table 174. Asia Furazolidone Sales by Application (2021-2026) & (K Units) Table 175. Asia Furazolidone Sales by Application (2027-2032) & (K Units) Table 176. Asia Furazolidone Sales Price by Application (2021-2026) & (US$/Unit) Table 177. Asia Furazolidone Sales Price by Application (2027-2032) & (US$/Unit) Table 178. Asia Furazolidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Asia Furazolidone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Asia Furazolidone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Asia Furazolidone Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 182. Asia Furazolidone Sales by Country (2021-2026) & (K Units) Table 183. Asia Furazolidone Sales by Country (2027-2032) & (K Units) Table 184. Asia Furazolidone Sales Price by Country (2021-2026) & (US$/Unit) Table 185. Asia Furazolidone Sales Price by Country (2027-2032) & (US$/Unit) Table 186. Japan Furazolidone Revenue (2021-2032) & (US$ Million) Table 187. South Korea Furazolidone Revenue (2021-2032) & (US$ Million) Table 188. India Furazolidone Revenue (2021-2032) & (US$ Million) Table 189. Australia Furazolidone Revenue (2021-2032) & (US$ Million) Table 190. China Taiwan Furazolidone Revenue (2021-2032) & (US$ Million) Table 191. Southeast Asia Furazolidone Revenue (2021-2032) & (US$ Million) Table 192. SAMEA Furazolidone Revenue by Type (2021-2026) & (US$ Million) Table 193. SAMEA Furazolidone Revenue by Type (2027-2032) & (US$ Million) Table 194. SAMEA Furazolidone Sales by Type (2021-2026) & (K Units) Table 195. SAMEA Furazolidone Sales by Type (2027-2032) & (K Units) Table 196. SAMEA Furazolidone Sales Price by Type (2021-2026) & (US$/Unit) Table 197. SAMEA Furazolidone Sales Price by Type (2027-2032) & (US$/Unit) Table 198. SAMEA Furazolidone Revenue by Application (2021-2026) & (US$ Million) Table 199. SAMEA Furazolidone Revenue by Application (2027-2032) & (US$ Million) Table 200. SAMEA Furazolidone Sales by Application (2021-2026) & (K Units) Table 201. SAMEA Furazolidone Sales by Application (2027-2032) & (K Units) Table 202. SAMEA Furazolidone Sales Price by Application (2021-2026) & (US$/Unit) Table 203. SAMEA Furazolidone Sales Price by Application (2027-2032) & (US$/Unit) Table 204. SAMEA Furazolidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. SAMEA Furazolidone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. SAMEA Furazolidone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. SAMEA Furazolidone Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 208. SAMEA Furazolidone Sales by Country (2021-2026) & (K Units) Table 209. SAMEA Furazolidone Sales by Country (2027-2032) & (K Units) Table 210. SAMEA Furazolidone Sales Price by Country (2021-2026) & (US$/Unit) Table 211. SAMEA Furazolidone Sales Price by Country (2027-2032) & (US$/Unit) Table 212. Brazil Furazolidone Revenue (2021-2032) & (US$ Million) Table 213. Argentina Furazolidone Revenue (2021-2032) & (US$ Million) Table 214. Chile Furazolidone Revenue (2021-2032) & (US$ Million) Table 215. Colombia Furazolidone Revenue (2021-2032) & (US$ Million) Table 216. Peru Furazolidone Revenue (2021-2032) & (US$ Million) Table 217. Saudi Arabia Furazolidone Revenue (2021-2032) & (US$ Million) Table 218. Israel Furazolidone Revenue (2021-2032) & (US$ Million) Table 219. UAE Furazolidone Revenue (2021-2032) & (US$ Million) Table 220. Turkey Furazolidone Revenue (2021-2032) & (US$ Million) Table 221. Iran Furazolidone Revenue (2021-2032) & (US$ Million) Table 222. Egypt Furazolidone Revenue (2021-2032) & (US$ Million) Table 223. Key Raw Materials Table 224. Raw Materials Key Suppliers Table 225. Furazolidone Distributors List Table 226. Furazolidone Customers List Table 227. Research Programs/Design for This Report Table 228. Authors List of This Report Table 229. Secondary Sources Table 230. Primary Sources List of Figures Figure 1. Furazolidone Image Figure 2. Global Furazolidone Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Furazolidone Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pharma Grade Image Figure 5. Industrial Grade Image Figure 6. Others Image Figure 7. Global Furazolidone Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Furazolidone Market Size Share 2021 VS 2025 VS 2032 Figure 9. Pharmacy Image Figure 10. Industry Image Figure 11. Global Furazolidone Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Furazolidone Revenue (2021-2032) & (US$ Million) Figure 13. Global Furazolidone Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Furazolidone Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Furazolidone Revenue Market Share by Region (2021-2032) Figure 16. Global Furazolidone Sales (2021-2032) & (K Units) Figure 17. Global Furazolidone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Furazolidone Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Furazolidone Sales YoY (2021-2032) & (K Units) Figure 20. Europe Furazolidone Sales YoY (2021-2032) & (K Units) Figure 21. China Furazolidone Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Furazolidone Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Furazolidone Sales YoY (2021-2032) & (K Units) Figure 24. Global Furazolidone Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Furazolidone Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Furazolidone Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Furazolidone Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Furazolidone Revenue Market Share by Type (2021-2032) Figure 30. Global Furazolidone Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Furazolidone Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Furazolidone Sales Market Share by Type (2021-2032) Figure 33. Global Furazolidone Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Furazolidone Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Furazolidone Revenue Market Share by Application (2021-2032) Figure 36. Global Furazolidone Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Furazolidone Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Furazolidone Sales Market Share by Application (2021-2032) Figure 39. North America Furazolidone Revenue Share by Type (2021-2032) Figure 40. North America Furazolidone Sales Share by Type (2021-2032) Figure 41. North America Furazolidone Revenue Share by Application (2021-2032) Figure 42. North America Furazolidone Sales Share by Application (2021-2032) Figure 43. North America Furazolidone Revenue Share by Country (2021-2032) Figure 44. North America Furazolidone Sales Share by Country (2021-2032) Figure 45. Europe Furazolidone Revenue Share by Type (2021-2032) Figure 46. Europe Furazolidone Sales Share by Type (2021-2032) Figure 47. Europe Furazolidone Revenue Share by Application (2021-2032) Figure 48. Europe Furazolidone Sales Share by Application (2021-2032) Figure 49. Europe Furazolidone Revenue Share by Country (2021-2032) Figure 50. Europe Furazolidone Sales Share by Country (2021-2032) Figure 51. China Furazolidone Revenue Share by Type (2021-2032) Figure 52. China Furazolidone Sales Share by Type (2021-2032) Figure 53. China Furazolidone Revenue Share by Application (2021-2032) Figure 54. China Furazolidone Sales Share by Application (2021-2032) Figure 55. Asia Furazolidone Revenue Share by Type (2021-2032) Figure 56. Asia Furazolidone Sales Share by Type (2021-2032) Figure 57. Asia Furazolidone Revenue Share by Application (2021-2032) Figure 58. Asia Furazolidone Sales Share by Application (2021-2032) Figure 59. Asia Furazolidone Revenue Share by Country (2021-2032) Figure 60. Asia Furazolidone Sales Share by Country (2021-2032) Figure 61. SAMEA Furazolidone Revenue Share by Type (2021-2032) Figure 62. SAMEA Furazolidone Sales Share by Type (2021-2032) Figure 63. SAMEA Furazolidone Revenue Share by Application (2021-2032) Figure 64. SAMEA Furazolidone Sales Share by Application (2021-2032) Figure 65. SAMEA Furazolidone Revenue Share by Country (2021-2032) Figure 66. SAMEA Furazolidone Sales Share by Country (2021-2032) Figure 67. Furazolidone Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Furazolidone Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Pharma Grade
  • Industrial Grade
  • Others
Applications
  • Pharmacy
  • Industry
Companies covered
  • Becton, Dickinson and Company (BD)
  • Daiichi Sankyo
  • Ferring
  • Geo-Med
  • GrÜNenthal Gmbh
  • Keyfarm
  • KPL Pharma
  • Marvi
  • Standpharm
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Furazolidone Market by Type
  3. 1.2.1 Global Furazolidone Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Pharma Grade
  5. 1.2.3 Industrial Grade
  6. 1.2.4 Others
  7. 1.3 Furazolidone Market by Application
  8. 1.3.1 Global Furazolidone Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Pharmacy
  10. 1.3.3 Industry
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Furazolidone Market Dynamics
  1. 2.1 Furazolidone Industry Trends
  2. 2.2 Furazolidone Industry Drivers
  3. 2.3 Furazolidone Industry Opportunities and Challenges
  4. 2.4 Furazolidone Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Furazolidone Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Furazolidone Revenue by Region
  3. 3.2.1 Global Furazolidone Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Furazolidone Revenue by Region (2021-2026)
  5. 3.2.3 Global Furazolidone Revenue by Region (2027-2032)
  6. 3.2.4 Global Furazolidone Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Furazolidone Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Furazolidone Sales by Region
  9. 3.4.1 Global Furazolidone Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Furazolidone Sales by Region (2021-2026)
  11. 3.4.3 Global Furazolidone Sales by Region (2027-2032)
  12. 3.4.4 Global Furazolidone Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Furazolidone Revenue by Manufacturers
  2. 4.1.1 Global Furazolidone Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Furazolidone Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Furazolidone Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Furazolidone Sales by Manufacturers
  6. 4.2.1 Global Furazolidone Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Furazolidone Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Furazolidone Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Furazolidone Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Furazolidone Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Furazolidone Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Furazolidone Manufacturers, Product Type & Application
  13. 4.7 Global Furazolidone Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Furazolidone Market CR5 and HHI
  16. 4.8.2 2025 Furazolidone Tier 1, Tier 2, and Tier 3
5 Furazolidone Market by Type
  1. 5.1 Global Furazolidone Revenue by Type
  2. 5.1.1 Global Furazolidone Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Furazolidone Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Furazolidone Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Furazolidone Sales by Type
  6. 5.2.1 Global Furazolidone Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Furazolidone Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Furazolidone Sales Market Share by Type (2021-2032)
  9. 5.3 Global Furazolidone Price by Type
6 Furazolidone Market by Application
  1. 6.1 Global Furazolidone Revenue by Application
  2. 6.1.1 Global Furazolidone Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Furazolidone Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Furazolidone Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Furazolidone Sales by Application
  6. 6.2.1 Global Furazolidone Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Furazolidone Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Furazolidone Sales Market Share by Application (2021-2032)
  9. 6.3 Global Furazolidone Price by Application
7 Company Profiles
  1. 7.1 Becton, Dickinson and Company (BD)
  2. 7.1.1 Becton, Dickinson and Company (BD) Company Information
  3. 7.1.2 Becton, Dickinson and Company (BD) Business Overview
  4. 7.1.3 Becton, Dickinson and Company (BD) Furazolidone Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Becton, Dickinson and Company (BD) Furazolidone Product Portfolio
  6. 7.1.5 Becton, Dickinson and Company (BD) Recent Developments
  7. 7.2 Daiichi Sankyo
  8. 7.2.1 Daiichi Sankyo Company Information
  9. 7.2.2 Daiichi Sankyo Business Overview
  10. 7.2.3 Daiichi Sankyo Furazolidone Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Daiichi Sankyo Furazolidone Product Portfolio
  12. 7.2.5 Daiichi Sankyo Recent Developments
  13. 7.3 Ferring
  14. 7.3.1 Ferring Company Information
  15. 7.3.2 Ferring Business Overview
  16. 7.3.3 Ferring Furazolidone Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Ferring Furazolidone Product Portfolio
  18. 7.3.5 Ferring Recent Developments
  19. 7.4 Geo-Med
  20. 7.4.1 Geo-Med Company Information
  21. 7.4.2 Geo-Med Business Overview
  22. 7.4.3 Geo-Med Furazolidone Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Geo-Med Furazolidone Product Portfolio
  24. 7.4.5 Geo-Med Recent Developments
  25. 7.5 GrÜNenthal Gmbh
  26. 7.5.1 GrÜNenthal Gmbh Company Information
  27. 7.5.2 GrÜNenthal Gmbh Business Overview
  28. 7.5.3 GrÜNenthal Gmbh Furazolidone Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 GrÜNenthal Gmbh Furazolidone Product Portfolio
  30. 7.5.5 GrÜNenthal Gmbh Recent Developments
  31. 7.6 Keyfarm
  32. 7.6.1 Keyfarm Company Information
  33. 7.6.2 Keyfarm Business Overview
  34. 7.6.3 Keyfarm Furazolidone Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Keyfarm Furazolidone Product Portfolio
  36. 7.6.5 Keyfarm Recent Developments
  37. 7.7 KPL Pharma
  38. 7.7.1 KPL Pharma Company Information
  39. 7.7.2 KPL Pharma Business Overview
  40. 7.7.3 KPL Pharma Furazolidone Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 KPL Pharma Furazolidone Product Portfolio
  42. 7.7.5 KPL Pharma Recent Developments
  43. 7.8 Marvi
  44. 7.8.1 Marvi Company Information
  45. 7.8.2 Marvi Business Overview
  46. 7.8.3 Marvi Furazolidone Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Marvi Furazolidone Product Portfolio
  48. 7.8.5 Marvi Recent Developments
  49. 7.9 Standpharm
  50. 7.9.1 Standpharm Company Information
  51. 7.9.2 Standpharm Business Overview
  52. 7.9.3 Standpharm Furazolidone Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Standpharm Furazolidone Product Portfolio
  54. 7.9.5 Standpharm Recent Developments
  55. 7.10 Teva
  56. 7.10.1 Teva Company Information
  57. 7.10.2 Teva Business Overview
  58. 7.10.3 Teva Furazolidone Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Teva Furazolidone Product Portfolio
  60. 7.10.5 Teva Recent Developments
8 North America
  1. 8.1 North America Furazolidone Market Size by Type
  2. 8.1.1 North America Furazolidone Revenue by Type (2021-2032)
  3. 8.1.2 North America Furazolidone Sales by Type (2021-2032)
  4. 8.1.3 North America Furazolidone Price by Type (2021-2032)
  5. 8.2 North America Furazolidone Market Size by Application
  6. 8.2.1 North America Furazolidone Revenue by Application (2021-2032)
  7. 8.2.2 North America Furazolidone Sales by Application (2021-2032)
  8. 8.2.3 North America Furazolidone Price by Application (2021-2032)
  9. 8.3 North America Furazolidone Market Size by Country
  10. 8.3.1 North America Furazolidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Furazolidone Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Furazolidone Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Furazolidone Market Size by Type
  2. 9.1.1 Europe Furazolidone Revenue by Type (2021-2032)
  3. 9.1.2 Europe Furazolidone Sales by Type (2021-2032)
  4. 9.1.3 Europe Furazolidone Price by Type (2021-2032)
  5. 9.2 Europe Furazolidone Market Size by Application
  6. 9.2.1 Europe Furazolidone Revenue by Application (2021-2032)
  7. 9.2.2 Europe Furazolidone Sales by Application (2021-2032)
  8. 9.2.3 Europe Furazolidone Price by Application (2021-2032)
  9. 9.3 Europe Furazolidone Market Size by Country
  10. 9.3.1 Europe Furazolidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Furazolidone Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Furazolidone Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Furazolidone Market Size by Type
  2. 10.1.1 China Furazolidone Revenue by Type (2021-2032)
  3. 10.1.2 China Furazolidone Sales by Type (2021-2032)
  4. 10.1.3 China Furazolidone Price by Type (2021-2032)
  5. 10.2 China Furazolidone Market Size by Application
  6. 10.2.1 China Furazolidone Revenue by Application (2021-2032)
  7. 10.2.2 China Furazolidone Sales by Application (2021-2032)
  8. 10.2.3 China Furazolidone Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Furazolidone Market Size by Type
  2. 11.1.1 Asia Furazolidone Revenue by Type (2021-2032)
  3. 11.1.2 Asia Furazolidone Sales by Type (2021-2032)
  4. 11.1.3 Asia Furazolidone Price by Type (2021-2032)
  5. 11.2 Asia Furazolidone Market Size by Application
  6. 11.2.1 Asia Furazolidone Revenue by Application (2021-2032)
  7. 11.2.2 Asia Furazolidone Sales by Application (2021-2032)
  8. 11.2.3 Asia Furazolidone Price by Application (2021-2032)
  9. 11.3 Asia Furazolidone Market Size by Country
  10. 11.3.1 Asia Furazolidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Furazolidone Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Furazolidone Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Furazolidone Market Size by Type
  2. 12.1.1 SAMEA Furazolidone Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Furazolidone Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Furazolidone Price by Type (2021-2032)
  5. 12.2 SAMEA Furazolidone Market Size by Application
  6. 12.2.1 SAMEA Furazolidone Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Furazolidone Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Furazolidone Price by Application (2021-2032)
  9. 12.3 SAMEA Furazolidone Market Size by Country
  10. 12.3.1 SAMEA Furazolidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Furazolidone Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Furazolidone Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Furazolidone Value Chain Analysis
  2. 13.1.1 Furazolidone Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Furazolidone Production Mode & Process
  6. 13.2 Furazolidone Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Furazolidone Distributors
  9. 13.2.3 Furazolidone Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst